Yi Gu

877 total citations
30 papers, 701 citations indexed

About

Yi Gu is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yi Gu has authored 30 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yi Gu's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (3 papers) and Cell Adhesion Molecules Research (3 papers). Yi Gu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (3 papers) and Cell Adhesion Molecules Research (3 papers). Yi Gu collaborates with scholars based in China, United States and Australia. Yi Gu's co-authors include Liu‐Zhu Gong, Hua Liu, Chang Guo, Shi‐Wei Luo, Qi‐Xiang Guo, Hui Chang, Lillian Skidmore, Feng Tian, Sulan Yao and Snezana Milutinovic and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Biomaterials.

In The Last Decade

Yi Gu

30 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Gu China 13 214 198 154 137 66 30 701
Mateusz Psurski Poland 15 169 0.8× 220 1.1× 107 0.7× 82 0.6× 41 0.6× 50 579
Yiying Lu China 14 123 0.6× 143 0.7× 118 0.8× 100 0.7× 96 1.5× 30 584
Guangyu Xu China 14 179 0.8× 415 2.1× 117 0.8× 53 0.4× 17 0.3× 60 791
Camila Maria Longo Machado Brazil 14 116 0.5× 257 1.3× 145 0.9× 78 0.6× 30 0.5× 28 742
Hyunjin Park South Korea 14 53 0.2× 316 1.6× 121 0.8× 39 0.3× 57 0.9× 31 598
Junying Zheng United States 17 41 0.2× 262 1.3× 77 0.5× 74 0.5× 16 0.2× 28 625
Yamixa Delgado Puerto Rico 13 78 0.4× 278 1.4× 105 0.7× 25 0.2× 156 2.4× 31 621
Jincheng Yang China 13 156 0.7× 214 1.1× 77 0.5× 24 0.2× 122 1.8× 38 583
Ana Brito Portugal 16 106 0.5× 208 1.1× 115 0.7× 46 0.3× 29 0.4× 22 641

Countries citing papers authored by Yi Gu

Since Specialization
Citations

This map shows the geographic impact of Yi Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Gu more than expected).

Fields of papers citing papers by Yi Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Gu. The network helps show where Yi Gu may publish in the future.

Co-authorship network of co-authors of Yi Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Gu. A scholar is included among the top collaborators of Yi Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Gu. Yi Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Tingting, Yi Gu, Qinghui Shou, et al.. (2023). Optimized silk fibroin nanoparticle functionalization with anti-CEA nanobody enhancing active targeting of colorectal cancer cells. Biomedical Materials. 18(4). 45027–45027. 2 indexed citations
2.
Gu, Yi, et al.. (2023). Development of a highly sensitive immunoassay based on pentameric nanobodies for carcinoembryonic antigen detection. Analytica Chimica Acta. 1279. 341840–341840. 12 indexed citations
3.
Gu, Yi, et al.. (2022). A novel silk fibroin protein–based fusion system for enhancing the expression of nanobodies in Escherichia coli. Applied Microbiology and Biotechnology. 106(5-6). 1967–1977. 15 indexed citations
4.
Gu, Yi, et al.. (2022). Targeting and neutralizing human epididymis protein 4 by novel nanobodies to suppress ovarian cancer cells and attenuate cisplatin resistance. International Journal of Biological Macromolecules. 199. 298–306. 3 indexed citations
5.
6.
Chen, Rui, Chenqi Zhu, Xu Liu, et al.. (2021). An injectable peptide hydrogel with excellent self-healing ability to continuously release salvianolic acid B for myocardial infarction. Biomaterials. 274. 120855–120855. 88 indexed citations
7.
Zhu, Hua, Jin Ding, Xiaoyi Chong, et al.. (2021). 2P Molecular imaging evaluation of a novel Claudin18.2 specific monoclonal antibody labeled with radionuclide. Annals of Oncology. 32. S1–S1. 1 indexed citations
8.
Skidmore, Lillian, Sukumar Sakamuri, Nick Knudsen, et al.. (2020). ARX788, a Site-specific Anti-HER2 Antibody–Drug Conjugate, Demonstrates Potent and Selective Activity in HER2-low and T-DM1–resistant Breast and Gastric Cancers. Molecular Cancer Therapeutics. 19(9). 1833–1843. 121 indexed citations
9.
10.
Gu, Yi, Hui Cao, Fēi Li, et al.. (2020). Production of functional human nerve growth factor from the submandibular glands of mice using a CRISPR/Cas9 genome editing system. World Journal of Microbiology and Biotechnology. 36(12). 176–176. 2 indexed citations
11.
Liu, Chang, et al.. (2020). Folate Intake and Risk of Pancreatic Cancer: A Systematic Review and Updated Meta-Analysis of Epidemiological Studies. Digestive Diseases and Sciences. 66(7). 2368–2379. 15 indexed citations
12.
Teng, Fei, Yi Gu, Huanhuan Guo, et al.. (2020). Abstract 5183: The preclinical characterization of TST001, a novel humanized anti-claudin18.2 mAb with enhanced binding affinity and anti-tumor activity. Cancer Research. 80(16_Supplement). 5183–5183. 6 indexed citations
13.
Zhu, Jingjing, Lillian Skidmore, Xuejun Liang, et al.. (2020). Nonclinical Development of Next-generation Site-specific HER2-targeting Antibody–drug Conjugate (ARX788) for Breast Cancer Treatment. Molecular Cancer Therapeutics. 19(9). 1822–1832. 22 indexed citations
14.
Guo, Ming, Xiaoyan Gao, Houhui Song, et al.. (2020). Anti-tumor effect of synthetic baicalin-rare earth metal complex drugs on SMMC-7721 cells. Environmental Geochemistry and Health. 42(11). 3851–3864. 5 indexed citations
15.
Gu, Yi, Jinsong Tang, Lili Wu, et al.. (2020). Characterization and applications of nanobodies against Pseudomonas aeruginosa Exotoxin A selected from single alpaca B cells. Biotechnology & Biotechnological Equipment. 34(1). 1028–1037. 3 indexed citations
16.
Guo, Ming, et al.. (2019). Chlorinated phosphorus flame retardants exert oxidative damage to SMMC-7721 human hepatocarcinoma cells. The Science of The Total Environment. 705. 135777–135777. 19 indexed citations
17.
Gu, Yi, et al.. (2019). Perfluorooctanoic acid exposure induces apoptosis in SMMC-7721 hepatocellular cancer cells. Environmental Pollution. 247. 509–514. 19 indexed citations
18.
Gu, Yi, Rui Sheng, Junchao Wu, Ying Zhou, & Zheng‐Hong Qin. (2018). Reduced nicotinamide adenine dinucleotide phosphate inhibits rat platelet aggregation and p38 phosphorylation. Thrombosis Research. 171. 121–129. 3 indexed citations
19.
Wang, Rong, et al.. (2012). Inhibition of tumor-induced angiogenesis and its mechanism by ardipusilloside I purified fromArdisia pusilla. Journal of Asian Natural Products Research. 14(1). 55–63. 7 indexed citations
20.
Huang, Xiaolun, Daniel J. Moore, Muhammad M. Mohiuddin, et al.. (2008). Inhibition of ICAM-1/LFA-1 Interactions Prevents B-Cell-Dependent Anti-CD45RB-Induced Transplantation Tolerance. Transplantation. 85(5). 675–680. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mateusz Psurski Breakdown of academic impact, for papers by Yiying Lu Breakdown of academic impact, for papers by Guangyu Xu Breakdown of academic impact, for papers by Camila Maria Longo Machado Breakdown of academic impact, for papers by Hyunjin Park Breakdown of academic impact, for papers by Junying Zheng Breakdown of academic impact, for papers by Yamixa Delgado Breakdown of academic impact, for papers by Jincheng Yang Breakdown of academic impact, for papers by Ana Brito
Rankless by CCL
2026